article_cache/bio.org/articles.json

[
  {
    "url": "https://www.bio.org/save/business-solutions",
    "title": "BIO Business Solutions",
    "text": "Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.\n\nSign up for the BIO.News Newsletter >\n\nJune 22-25, 2026 | San Diego, CA\n\nNovember 3-5, 2025Vienna, Austria\n\nJanuary 12-15, 2026San Francisco, CA\n\nExplore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.\n\nOur tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.\n\nMore savings. More research.888.246.1728   •   save@bio.org\n\nPower your research with savings on lab supplies, refurbished equipment, cleanroom services, gas, lab waste, and more.\n\nSimplify operations with exclusive pricing on business insurance, clinical trial coverage, HR support, payroll, and employee benefits.\n\nReduce overhead with preferred pricing on shipping, office supplies, quality software, travel, and other essential services.\n\nBIO Business Solutions offers StemBioSys access to world-class business partners at preferred prices. For a small company like ours, this combination is clearly a win-win proposition!\n\nBIO’s Cost Savings Program provided us outstanding benefits as we expanded into a new lab space. We obtained savings on lab equipment, supplies, and services and continue to get the support we need.\n\nBIO Business Solutions is the largest cost savings program for the life sciences industry, operated by BIO. BIO Business Solutions negotiates significant volume-based discounts, favorable terms, and other benefits on products and services with industry leading suppliers on behalf of BIO members and the members of state and regional biotech associations.\n\nThe Biotechnology Innovation Organization (BIO) is the world’s largest trade association representing the life sciences industry. BIO members are leading the research and development of innovative healthcare, agriculture, industrial, and environmental products. We bring members together with others in the industry and advocate around the world for policies and regulations that support the needs of biotech businesses large and small.\n\nThe BIO Business Solutions program is available to all BIO member companies and of members of all participating state and regional biotech associations. There is no charge for member companies to participate in the program as it is a benefit of membership. Member companies can take advantage of one, some, or all of the special pricing arrangements offered through the BIO Business Solutions program.Click here for a list of state/regional associationsthat offer BIO Business Solutions to their member companies.\n\nOver 4,700 companies currently use BIO Business Solutions and, together, save over $705 million annually through the program. The discounted prices and value-added features available are negotiated based on the pooled buying power of thousands of life sciences companies of all sizes across North America, giving you the same purchasing power as the largest life sciences companies.\n\nBIO partners with a network of independent state and regional life science associations (BIO’s network of state affiliates) to support policy initiatives and business development activity. These state affiliates provide BIO with “grassroots” support. As part of our partnership with the state affiliates, BIO makes the BIO Business Solutions program available to their members. The members of participating state associations may also use the program at no additional charge, as the program is a benefit of their memberships.\n\nWhile some of the individual BIO Business Solutions programs are relevant only to life science companies, a few programs are applicable and available to any company in any industry!",
    "author": "Unknown",
    "date": "Unknown",
    "category": "Save",
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/news/issue-briefs",
    "title": "Toolkit for Advocates",
    "text": "Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.\n\nSign up for the BIO.News Newsletter >\n\nJune 22-25, 2026 | San Diego, CA\n\nNovember 3-5, 2025Vienna, Austria\n\nJanuary 12-15, 2026San Francisco, CA\n\nExplore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.\n\nOur tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.\n\nWe’ve made it easier for you to access information and share content about biotechnology and how it improves our daily lives, from prescription medications and a resilient food supply to renewable energy and sustainable bioprocessing materials. Click on or flip over any of the cards below to learn more about a topic. The information you discover can easily be shared on Twitter, Facebook and LinkedIn.\n\nBuild your network, stay on top of industry topics, advocate for issues critical to your interests, gain access to policymakers, and save money.",
    "author": "Unknown",
    "date": "Unknown",
    "category": "News",
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/policy/international/global-markets-trade",
    "title": "Global Markets & Trade",
    "text": "Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.\n\nSign up for the BIO.News Newsletter >\n\nJune 22-25, 2026 | San Diego, CA\n\nNovember 3-5, 2025Vienna, Austria\n\nJanuary 12-15, 2026San Francisco, CA\n\nExplore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.\n\nOur tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.\n\nWe engage policymakers and industry partners globally to encourage the adoption of national laws and regulations to support the development of the biotechnology sector.  Pursuing biotechnology specific outcomes within new trade agreements and modernizing older agreements is important as the biotechnology sector is increasingly global, requiring rules to govern the trade in biotechnology product and foster cross-border collaboration.",
    "author": "Unknown",
    "date": "Unknown",
    "category": "Policy",
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/privacy-policy",
    "title": "Privacy Policy",
    "text": "Thank you for visiting a member of the Biotechnology Innovation Organization (BIO) family of websites.  BIO and possibly affiliated organizations (“BIO” “we,” “our,” “us”) maintain these sites (each, strictly for reference in this privacy policy, a “BIO Site” and collectively “BIO Sites”). This privacy policy (the \"Privacy Policy\") applies to BIO Sites, mobile applications, and other online services that link to this Privacy Policy (the “Services”). By using the Services, you agree to the terms of this Privacy Policy.  In addition, by using the Services, you agree to the terms of the BIO TERMS OF USE, which govern your use of the Services.   Please note that the Privacy Policy does not apply to other websites of other companies, organizations or our members to which we may link, third party sites that link to us, or to our off-line activities.\n\nIF YOU DO NOT AGREE WITH ANY TERMS OR PRACTICES DESCRIBED IN THIS PRIVACY POLICY, OR BIO’S TERMS OF USE, THEN PLEASE DO NOT USE THE SERVICES.\n\nGenerally, you are not required to provide information about yourself when you visit the Services.  You can browse most of our BIO Sites and view our content anonymously (except regarding some information like Google analytics or “informatics”).  The type and amount of information BIO collects about you varies according to how you use the Services, BIO Sites or other BIO operations and events.  However, we may ask you for (or collect from you) some or all of the following types of information when you access various content or features, submit information to us, or directly contact us with questions or feedback:\n\nAnd, for example, we may collect certain information automatically when you visit the Services, including:\n\nWe may use information that we collect through the Services for a variety of purposes, including, but not limited to:\n\nWe seek to maintain your trust, and we want you to understand when and with whom we may share the information we collect:\n\nIn addition, we may allow third parties to place and read cookies, web beacons, Local Shared Objects, and similar technologies to collect information through the Services.  For example, our third-party service providers may use these technologies to collect information that helps us with traffic measurement, research, and analytics.\n\nNote, online fora (e.g. blogs, Facebook postings, etc.) may be publicly accessible and other users may view information you post on them.\n\nThere are certain BIO Sites and features that require you to provide (voluntary and at your option) certain personal information before you may participate in the respective BIO Site (e.g., contest/sweepstakes; subscribe to newsletter).  In addition, when you make a purchase, or sign up for a paid service, we will also collect your credit card information as additional personal information.  We will use your credit card information only to complete the transaction you have requested.\n\nSome personal information you have provided may be used in combination with other information obtained through other means.  For example, we may use your name, company, and e-mail address provided to us online in conjunction with our membership records in order to provide you with a user name and password to access a BIO Site, forum, or specialized area.  In other instances, an online inquiry about a purchase from us may prompt a review of an order placed by you over the telephone.\n\nBIO also reserves the right to sell or license the use of information collected from the Services. However, it is our policy to not disclose externally with third parties personal information collected on our site, except in the following instances:\n\nOther than as set forth above, we currently do not intend to share your personal information with third parties for other purposes.  However, in the future, we may disclose personal information you have provided to third parties for additional purposes. In the event we do, we will provide notice of such use to our users as appropriate, i.e. to those that have allowed us to communicate with them.\n\nChildren's Online Privacy Protection Act (COPPA)\n\nWe do not solicit or knowingly collect information from minors under the age of 13, in compliance with the Children's Online Privacy Protection Act (COPPA).  For more information about COPPA, please visit:http://www.ftc.gov/opa/2010/03/coppa.shtm.\n\nInformation Correction or Changes\n\nYou have the ability to correct or change certain information in our records, such as your address and contact information.  Generally, you may change this information at any time and as often as necessary.  If you need assistance or have questions about correcting information, you can contact us via e-mail atinfo@bio.org.\n\nIf you have provided us with your e-mail address or mobile phone number to subscribe to a Service or services, or to receive notifications or updates about one of our offerings, and you wish to change your address or no longer wish to receive these communications, simply follow the unsubscribe instructions that appear on our sites or in the e-mail or text message communications.\n\nPlease note, any information we have collected may remain in back-up storage, archival, and/or log files, for some period of time after a deletion request.  This may be the case even though no information about your account remains actively used as described in this Privacy Policy.\n\nAny mobile information that BIO obtains from its use of Zoom Phone will not be sold to any third party (i.e., parties that are not members or affiliates of BIO) for marketing or promotional purposes, and may be used for the benefit of BIO, its members, and its affiliates. This statement will not apply to any information provided by someone who has given permission to share, sell, or disclose such information.\n\nWe have industry standard security procedures and best practices to help protect against loss, misuse, and unauthorized access to the information you provide to us.  Please note, any data transmission or storage cannot be guaranteed to be 100% secure.  As a result, while we strive to protect your information and privacy, we cannot guarantee or warrant the security of any information you disclose or transmit to the Services or services and cannot be responsible for the theft, destruction, or inadvertent disclosure of your information.\n\nIn the event that BIO is acquired by or merged with another company, or in connection with the potential sale or transfer of some or all of the assets of our websites, BIO reserves the right to sell, license or transfer to a third party entity your information.\n\nWe do not share information that we collect with third parties for the third party’s direct marketing purposes.\n\nSome web browsers may transmit “do-not-track” signals to the websites with which the user communicates.  Because of differences in how web browsers incorporate and activate this feature, it is not always clear whether users intend for these signals to be transmitted, or whether they even are aware of them.  Because there currently is no industry standard concerning what, if anything, websites should do when they receive such signals, we currently do not take action in response to these signals.  If and when a final standard is established and accepted, we will reassess how to respond to these signals.  In some cases, third parties may be able to collect information about a user’s online activities over time and across different websites when he or she uses our Services.\n\nWe have worked with certain third-party social media providers to offer social networking services through the Services.  For example, you can use third-party social networking services, including but not limited to Facebook, Twitter, and others to share information about your experience on our Services with your friends and followers on those social networking services.  These social networking services may be able to collect information about you, including your activity on our Services.  These third-party social networking services also may notify your friends, both on our Services and on the social networking services themselves, that you are a user of our Services or about your use of our Services, in accordance with applicable law and their own privacy policies.  If you choose to access or make use of third-party social networking services, we may receive information about you that you have made available to those social networking services, including information about your contacts on those social networking services.\n\nPeriodically we may make changes to this policy.  You are responsible for periodically checking our Services for changes to this Privacy Policy. Your continued use our Services after these changes are posted constitutes your agreement to the changes with regard to any information collected.\n\nWe welcome your feedback regarding this Privacy Policy.  If you have any comments, questions or concerns about this privacy policy you may contact us at:\n\nBiotechnology Innovation Organization1201 New York Ave. NWWashington, DC 20005Tele:       (202) 962-9200Fax:        (202) 488-6301E-Mail:info@bio.org\n\nThis Privacy Policy was updated on September 2024.",
    "author": "Unknown",
    "date": "Unknown",
    "category": null,
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "http://www.ftc.gov/opa/2010/03/coppa.shtm",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/policy/international",
    "title": "International",
    "text": "Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.\n\nSign up for the BIO.News Newsletter >\n\nJune 22-25, 2026 | San Diego, CA\n\nNovember 3-5, 2025Vienna, Austria\n\nJanuary 12-15, 2026San Francisco, CA\n\nExplore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.\n\nOur tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.\n\nBIO promotes science-based policies and protect market-based incentives to enable the growth of the global biotechnology ecosystem.\n\nGlobal collaboration is increasingly important as governments around the world seek to develop comprehensive policy frameworks to support biotechnology innovation. Through collaboration and dialogue, we can create a global policy environment that enables the biotechnology sector to meet societal needs, such as treating and curing disease, mitigating climate change and feeding a growing global population.\n\nWe work with the International Council of Biotechnology Associations to support our engagement with governments and advocate for public policies that support the growth and connection of the innovative biotechnology industry worldwide. .\n\nBuilding a strong biotechnology sector is a strategic priority and part of an increasing number of countries’ economic vision. Through a collaboration with thePugatch Consilium, BIO helps governments understand the best ways to encourage innovation and attract investment. The report “Building the Bioeconomy” evaluates countries’ progress towards building their bioeconomies with a data-driven approach, comparing economies with over 20 policy inputs and biotech outputs showing how regulations affect success or failure in driving industry growth.\n\nAt the annual BIO International Convention, BIO provides a forum to highlight biotech initiatives in global markets, looking at both emerging economies and other global initiatives and trends (trade agreements, IP trends) that affect the industry’s landscape.  The Forum provides an overview of developments in key markets, as well as cross-cutting policy trends. It also examines unique collaborations and cross-border initiatives to further innovation.\n\nBIO works with partners around the world to host events aimed at enabling dialogue between governments and industry, as well as creating business development opportunities for entrepreneurs. Learn more aboutBIO’s international event portfolio.",
    "author": "Unknown",
    "date": "Unknown",
    "category": "Policy",
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "http://internationalbiotech.org",
      "http://internationalbiotech.org",
      "http://www.pugatch-consilium.com/",
      "https://www.pugatch-consilium.com/reports/BIO%202019%20report_final.pdf",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/policy/human-health",
    "title": "Human Health",
    "text": "Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.\n\nSign up for the BIO.News Newsletter >\n\nJune 22-25, 2026 | San Diego, CA\n\nNovember 3-5, 2025Vienna, Austria\n\nJanuary 12-15, 2026San Francisco, CA\n\nExplore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.\n\nOur tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.\n\nModern biotechnology provides breakthrough products and technologies to combat debilitating diseases. Innovative medicines and cures help people lead longer, healthier lives and positively impact society by providing economic value far beyond their cost. To ensure these transformative therapies get to the people who need them, BIO is committed to advancing policies that foster innovation, fuel investment and encourage the entrepreneurial spirit that has made America the global leader in this cutting-edge field.\n\nSign-up to join BIOAction, BIO's grassroots advocacy program. You will be notified about relevant policy issues where we need you to contact your lawmaker.\n\nWe’ve made it easier for you to access information and share content about biotechnology and prescription medicines. Learn more about dozens of topics and then share information you discover on Twitter, Facebook, and LinkedIn.\n\nJune 22-25, 2026 | San Diego, CA",
    "author": "Unknown",
    "date": "Unknown",
    "category": "Policy",
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://www.drugcostfacts.org/",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/policy/human-health/cost-value-biopharmaceuticals",
    "title": "Cost & Value of Biopharmaceuticals",
    "text": "Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.\n\nSign up for the BIO.News Newsletter >\n\nJune 22-25, 2026 | San Diego, CA\n\nNovember 3-5, 2025Vienna, Austria\n\nJanuary 12-15, 2026San Francisco, CA\n\nExplore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.\n\nOur tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.\n\nBiopharmaceutical innovation saves lives. It also saves money. Every reduced hospital stay, every surgery avoided, every inoculation can help reduce health care costs and help ensure a better quality of life for friends and loved ones. We are making important progress in addressing the diseases that steal our time with loved ones and burden our health care system.\n\nPolicymakers in Washington D.C. have offered various drug pricing proposals that would replace the current free and fair market-based system for determining the value of prescription medicines with a system based on international reference pricing.\n\nSign-up to join BIOAction, BIO's grassroots advocacy program. You will be notified about relevant policy issues where we need you to contact your lawmaker.\n\nWe’ve made it easier for you to access information and share content about biotechnology and prescription medicines. Learn more about dozens of topics and then share information you discover on Twitter, Facebook, and LinkedIn.",
    "author": "Unknown",
    "date": "Unknown",
    "category": "Policy",
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/policy/intellectual-property",
    "title": "Intellectual Property",
    "text": "Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.\n\nSign up for the BIO.News Newsletter >\n\nJune 22-25, 2026 | San Diego, CA\n\nNovember 3-5, 2025Vienna, Austria\n\nJanuary 12-15, 2026San Francisco, CA\n\nExplore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.\n\nOur tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.\n\nKeeping America CompetitiveStrong patents, and an efficient, predictable, and objective patent system, are critical to ensuring that America continues to leads the world in innovation, providing the United States with a global competitive advantage and spurring economic growth and the creation of high-paying jobs here at home.Creating BreakthroughsStrong, reliable IP protections allow startups to turn breakthrough science into lifesaving treatments — which is no easy feat. Roughlynine in 10medicines ultimately fail in clinical trials. Without IP, the financial risks of drug development would be insurmountable.\n\nPutting U.S. Patients FirstA strong patent system ensures that U.S. patients continue to have priority access to first-in-class treatments — as well as the best and newest formulations of existing medicines. On average, new drugs are launched in the U.S. afull yearbefore they hit other major markets like Germany and Canada.\n\nA robust, predictable IP system fuels the drug development cycle — protecting discoveries, incentivizing risk-taking, and driving the next generation of breakthroughs. By safeguarding IP, we safeguard America's global leadership, ensuring we'll continue to out-innovate China. Over the past decade, China has increased its biopharma R&D spending400-fold.\n\nFor biotech startups, IP is often the only asset that attracts the investment needed to fund early-stage innovation. Weakening IP protections chokes off this critical funding pipeline — and advantages foreign competitors. \"Biotech firms with robust patent portfolios attract investment 4-5 times faster than those without strategic IP protection,\" according toglobal industry data.\n\nIP protections underpin the biotech sector’s ability to operate and to fuel economic growth, offer high-paying jobs, and revitalize local communities. The U.S. bioscience industry supports over10 million jobs and $3 trillionin total economic output.\n\nAdvancing newer and better medicines, therapeutics, and vaccines is a collective effort that involves an entire ecosystem, not just one person or company. This virtuous circle of innovation often begins with a patient or family expressing a need, and is followed by researchers responding with innovative ideas. BIO's role is to protect, advance, and enlarge this innovation ecosystem.\n\n\"The role of BIO is going to be to make sure that that entire innovation ecosystem, that virtuous circle, is protected and advanced.”- BIO President & CEO John F. Crowley\n\nEvery new medicine starts with an idea - sometimes in a lab, sometimes far outside it. From that first spark, innovators take on the high-risk, multi-step journey that turns discoveries into treatments and cures.Step 1 -Spark an IdeaBiotech innovation often begins by exploring ways to connect scientific insights to unmet medical needs. U.S. firms originate61%of FDA-approved medicines.\n\nNovember 17-19, 2025・Palm Springs, CAThis is the only conference focused specifically on intellectual property in biotechnology, featuring the latest insights from biotech IP experts, as well as networking events designed to promote discussion and foster relationships among industry colleagues. You'll come away with practical information you can put into use at your organization the next day.The conference is open to both BIO Members and non-members who work or are interested in intellectual property rights.\n\nBIO works with the United States Patent and Trademark Office’s (USPTO)IP attaché program, which strives to improve Intellectual property (IP) systems internationally for the benefit of U.S. stakeholders. IP attachés are posted at U.S. missions around the world to address IP issues arising in their assigned regions.",
    "author": "Unknown",
    "date": "Unknown",
    "category": "Policy",
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://pmc.ncbi.nlm.nih.gov/articles/PMC9293739/",
      "https://www.rand.org/pubs/research_reports/RRA788-4.html",
      "https://www.biotech.senate.gov/wp-content/uploads/2025/04/NSCEB-Full-Report-%E2%80%93-Digital-%E2%80%934.28.pdf#page=8",
      "https://www.efbpublic.org/biotech-ip-strategy/",
      "https://bio.widen.net/s/hflmb92hwx/the-us-bioscience-economy-driving-economic-growth-and-opportunities-in-states-and-regions",
      "https://www.uspto.gov/ipattache",
      "https://www.uspto.gov/learning-and-resources/ip-policy/intellectual-property-attach-program/find-attach",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/policy/international/multilateral-organizations",
    "title": "Multilateral Organizations",
    "text": "Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.\n\nSign up for the BIO.News Newsletter >\n\nJune 22-25, 2026 | San Diego, CA\n\nNovember 3-5, 2025Vienna, Austria\n\nJanuary 12-15, 2026San Francisco, CA\n\nExplore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.\n\nOur tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.\n\nWe engage key officials within multilateral institutions, such as, the World Health Organization (WHO), World Intellectual Property Organization (WIPO), the World Trade Organization (WTO), to promote policies and collaborations that support innovation so that biotechnology can be fully deployed to help countries achieve their U.N. Sustainable Development Goals.\n\nThe United Nations General Assembly created the Sustainable Development Goals (SDGs) in 2015 as a blueprint to achieve a better and more sustainable future for all. The collection of 17 goals and 169 targets aim to address poverty, climate, environmental degradation, prosperity, and health, and these goals drive the works of countries, United Nations Agencies, non-governmental organizations, and companies around the world. And biotechnology is a critical tool in helping achieve many of the SDGs.\n\nTheInternational Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH)is a unique forum that enables regulatory authorities globally to harmonize regulations to ensure that safe, effective, and high quality medicines are developed and registered in the most resource-efficient manner. BIO is a member of ICH and we regularly contribute real-world industry experience to ICH work streams.",
    "author": "Unknown",
    "date": "Unknown",
    "category": "Policy",
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://www.ich.org/",
      "https://www.ich.org/",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/policy/human-health/drug-development-review-lifecycle-management",
    "title": "Drug Development, Review & Lifecycle Management",
    "text": "Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.\n\nSign up for the BIO.News Newsletter >\n\nJune 22-25, 2026 | San Diego, CA\n\nNovember 3-5, 2025Vienna, Austria\n\nJanuary 12-15, 2026San Francisco, CA\n\nExplore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.\n\nOur tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.\n\nBefore a therapy is approved for delivery to patients a lot of hard work and research goes into demonstrating that the therapy is safe, effective, and high quality. We work to promote a regulatory environment that supports safe and efficient development and approval of therapies to treat patients afflicted with serious diseases, to delay the onset of these diseases, or to prevent them in the first place.\n\nIn September 2017, FDA implemented the Patient Experience Data table (PED Table) to be completed by reviewers and included in NDA/BLA review documents...\n\nSign-up to join BIOAction, BIO's grassroots advocacy program. You will be notified about relevant policy issues where we need you to contact your lawmaker.",
    "author": "Unknown",
    "date": "Unknown",
    "category": "Policy",
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/policy/human-health/antimicrobial-resistance",
    "title": "Antimicrobial Resistance",
    "text": "Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.\n\nSign up for the BIO.News Newsletter >\n\nJune 22-25, 2026 | San Diego, CA\n\nNovember 3-5, 2025Vienna, Austria\n\nJanuary 12-15, 2026San Francisco, CA\n\nExplore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.\n\nOur tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.\n\nAntimicrobial resistance (AMR) was associated with nearly5 million deathsaround the world in 2019. The number of fatalities is expected to grow tonearly 170 million deaths by 2050. AMR is one of the most serious public health threats today, but the market for antimicrobial development is broken.\n\nThis report investigates recent investment into antibacterial innovation and the current clinical pipeline that will help bridge the gaps in the antibacterial armamentarium.\n\nWorking to Fight AMR aims to raise awareness of the threat of AMR and policy solutions that will help encourage the development of new antimicrobial medicines. Keep up with the latest AMR news, fact sheets, and more.",
    "author": "Unknown",
    "date": "Unknown",
    "category": "Policy",
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02724-0/fulltext",
      "https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01867-1/fulltext",
      "https://bio.news/health/amr-unga-antimicrobial-resistance-un-2024-lancet-study/",
      "https://bio.news/health/amr-unga-antimicrobial-resistance-un-2024-lancet-study/",
      "https://bio.news/health/amr-unga-antimicrobial-resistance-un-2024-lancet-study/",
      "https://bio.news/biosecurity/antimicrobial-resistance-crisis-amr-ucla-bio-pasteur-act/",
      "https://bio.news/biosecurity/antimicrobial-resistance-crisis-amr-ucla-bio-pasteur-act/",
      "https://bio.news/biosecurity/antimicrobial-resistance-crisis-amr-ucla-bio-pasteur-act/",
      "https://bio.news/health/amr-infections-increased-20-during-covid-19-and-continue-to-pose-a-threat/",
      "https://bio.news/health/amr-infections-increased-20-during-covid-19-and-continue-to-pose-a-threat/",
      "https://bio.news/health/amr-infections-increased-20-during-covid-19-and-continue-to-pose-a-threat/",
      "https://bio.news/latest-news/legislation-to-fight-amr-superbugs-is-an-urgent-need-bio-member-tells-senate-hearing/",
      "https://bio.news/latest-news/legislation-to-fight-amr-superbugs-is-an-urgent-need-bio-member-tells-senate-hearing/",
      "https://bio.news/latest-news/legislation-to-fight-amr-superbugs-is-an-urgent-need-bio-member-tells-senate-hearing/",
      "https://bio.news/latest-news/hearing-on-public-health-threat-from-amr-puts-spotlight-on-pasteur-act/",
      "https://bio.news/latest-news/hearing-on-public-health-threat-from-amr-puts-spotlight-on-pasteur-act/",
      "https://bio.news/latest-news/hearing-on-public-health-threat-from-amr-puts-spotlight-on-pasteur-act/",
      "https://bio.news/health/pasteur-act-reintroduced-in-house-senate-amr-antimicrobial-resistance-antibiotics/",
      "https://bio.news/health/pasteur-act-reintroduced-in-house-senate-amr-antimicrobial-resistance-antibiotics/",
      "https://bio.news/health/pasteur-act-reintroduced-in-house-senate-amr-antimicrobial-resistance-antibiotics/",
      "https://bio.news/health/a-patient-was-desperate-to-stop-his-drug-resistant-infection-and-without-action-he-wont-be-the-last/",
      "https://bio.news/health/a-patient-was-desperate-to-stop-his-drug-resistant-infection-and-without-action-he-wont-be-the-last/",
      "https://bio.news/health/a-patient-was-desperate-to-stop-his-drug-resistant-infection-and-without-action-he-wont-be-the-last/",
      "https://workingtofightamr.org/media-center/",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/bios-priorities",
    "title": "BIO's Six Core Strategic Priorities",
    "text": "Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.\n\nSign up for the BIO.News Newsletter >\n\nJune 22-25, 2026 | San Diego, CA\n\nNovember 3-5, 2025Vienna, Austria\n\nJanuary 12-15, 2026San Francisco, CA\n\nExplore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.\n\nOur tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.\n\nBIO is committed to speaking up for the millions of families around the world who depend upon our success.\n\nExplore how we drive biotechnology innovation. Advancing newer and better medicines, therapeutics, and vaccines is a collective effort that involves an entire ecosystem, not just one person or company. This virtuous circle of innovation often begins with a patient or family expressing a need, and is followed by researchers at academic centers responding with innovative ideas. BIO's role is to protect, advance, and enlarge this innovation ecosystem.\n\nInnovation defines our mission and future direction, but innovation alone is not enough without universal access. No one should go without essential medicines. We must understand why this happens and address it. BIO is uniquely positioned to convene discussions, propose solutions, and help ensure universal access for all.\n\nWe must share the stories of lives transformed by medical miracles. It is crucial to highlight those in need, offering hope through their stories of perseverance and passion that define biotechnology's uniqueness. We must also spotlight extraordinary successes, challenges faced, and the important lessons learned from failures in the pursuit of life-changing innovation.\n\nEvery decision we make in the biotechnology industry should be guided by empathy. Imagine if you or a loved one faced a challenging disease—what choices would you hope for? Bringing this passion and purpose to our work not only makes for fulfilling careers, but also has a profound impact on the work we do and those we serve. In some thereapeutic areas, we may be changing small parts of the world, but for individuals and families affected by these conditions, our efforts mean the world.\n\nThe biotechnology industry is a critical national security asset. We must consider how to prepare for future pandemics and respond to potential bioterror attacks. Resilience and the ability to safeguard public health in extreme circumstances are paramount. Ensuring a vibrant public health system demonstrates the benefits of a free and democratic society. Collaboratively, entrepreneurs and companies can not only serve U.S. citizens and allies, but also benefit the entire globe.\n\nWe need to broaden our perspective on membership in BIO—not just in technical terms, but for individuals who recognize their stake in the success of biotechnology. It's crucial to connect at a personal level, showing why new medicines, vaccines for individuals, their children, and future generations. We are entering a new era of biotechnology, and we must demonstrate its immense value to all people.",
    "author": "Unknown",
    "date": "Unknown",
    "category": null,
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/member/join-committees-have-voice",
    "title": "Join Committees - Have a Voice",
    "text": "Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.\n\nSign up for the BIO.News Newsletter >\n\nJune 22-25, 2026 | San Diego, CA\n\nNovember 3-5, 2025Vienna, Austria\n\nJanuary 12-15, 2026San Francisco, CA\n\nExplore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.\n\nOur tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.\n\nAll BIO members have a voice, and our policy initiatives reflect the diversity of our membership. BIO members are able to participate in committees to provide a unified voice on policy and advocacy issues in the biotech community.\n\n\"BIO is a crucial trade group representing all biotech and biopharma companies with influence on policies affecting our business and patients with rare diseases in the U.S. Through our participation in the BIO PARC, we have collaborated with staff to shape regulatory policy and amplify our company's voice.\"\n\nJudit IllesDirector, Government Affairs & Public PolicyPTC Therapeutics, Inc.\n\nJoin committees and working groups focused on Science & Regulatory Affairs, Policy & Reimbursement, Infectious Disease, Finance, Government Relations, International Affairs, Alliance Development, Legal & Intellectual Property, and Communications.\n\nCommittee participation is open to all employees of BIO member companies, and each individual can choose their degree of involvement. Participate in committee calls to speak up about issues that are important to you, network with peers, or simply stay informed.\n\nContact the Membership Team with questions or to request to join a committee.\n\nParticipation in BIO committees is open to employees of BIO member R&D-focused companies only. If your company is not yet a BIO member, join us!",
    "author": "Unknown",
    "date": "Unknown",
    "category": "Member",
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/policy/human-health/vaccines-biodefense",
    "title": "Vaccines & Biodefense",
    "text": "Webinar recorded on June 30, 2022, and moderated by Phyllis Arthur, Vice President, Infectious Disease and Emerging Science Policy, BIO.  Webinar slides are available atthis link.\n\nThe US Government invests in biomedical research in many ways, including direct funding of some critical R&D areas for diagnostics, vaccines, and therapeutics that could strengthen biodefense preparedness. This three-part webinar details for the biotechnology corporate and academic community the many new and previously available sources of capital, as well as the processes for applying for funding, from the US Department of Defense.\n\nThe Department of Defense (DoD) is continuously engaging in efforts to protect the warfighter from a broad array of threats. Preparing for and responding to these threats requires key partnerships with the industry to develop vaccines, therapeutics, and diagnostics that are designed specifically to meet the unique needs of the warfighter in various situations. Many of the investments made through these partnerships also support broader applications of key biotechnologies for other unmet healthcare needs. This important webinar represents an opportunity for BIO members and the whole biotechnology community to get an update about the priorities and programs within the DoD and the ways companies can work with the Agency on their priorities.\n\nPart 1—Opening Remarks on DoD Priorities and Investing at the Speed of Need: Novel Technologies and Platforms to Accelerate Drug Development (60 minutes)Part 2—Repurposing and Redirecting: An Alternate Approach to Accelerating Medical Countermeasures (42 minutes)Part 3—How to Work with DoD (16 minutes)",
    "author": "Unknown",
    "date": "Unknown",
    "category": "Policy",
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/bestpractices",
    "title": "The U.S. Bioscience Industry: A Powerful Engine for State Economies",
    "text": "Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.\n\nSign up for the BIO.News Newsletter >\n\nJune 22-25, 2026 | San Diego, CA\n\nNovember 3-5, 2025Vienna, Austria\n\nJanuary 12-15, 2026San Francisco, CA\n\nExplore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.\n\nOur tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.",
    "author": "Unknown",
    "date": "Unknown",
    "category": "Bestpractices",
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/terms-use",
    "title": "Terms of Use",
    "text": "Welcome to the Internet Sites of the Biotechnology Innovation Organization (\"BIO\"), the trade association representing the U.S. biotechnology industry.  BIO and any affiliated companies (referred to herein as \"BIO,\" \"we,\" \"us,\" or \"our\") maintain these sites (each a \"BIO Site\" and collectively \"BIO Sites\").\n\nBY USING A BIO SITE, YOU SIGNIFY YOUR AGREEMENT TO ALL TERMS, CONDITIONS, AND NOTICES CONTAINED OR REFERENCED IN THESE TERMS & CONDITIONS (THE \"TERMS & CONDITIONS\" OR \"TERMS\") ON OUR SITES.  IF YOU DO NOT AGREE TO THESE TERMS & CONDITIONS YOU ARE NOT AUTHORIZED TO USE BIO SITES.  WE RESERVE THE RIGHT, AT OUR DISCRETION, TO CHANGE, MODIFY, ADD TO, OR REMOVE PORTIONS OF THESE TERMS AT ANY TIME WITHOUT NOTICE.  PLEASE CHECK THE TERMS PERIODICALLY FOR CHANGES. YOUR CONTINUED USE OF BIO SITES FOLLOWING THE POSTING OF ANY CHANGES TO THESE TERMS CONSTITUTES ACCEPTANCE OF THOSE CHANGES.\n\nSome BIO Sites or areas of Sites may have different terms and conditions posted.  Any such terms will not vary or replace these Terms & Conditions regarding the use of BIO Sites, unless they expressly state otherwise.  Additionally, a BIO Site may contain page(s) or areas with their own Terms & Conditions, in addition to those listed here, which you should review and with which you must agree in order to use those areas.\n\nCopyright, Trademarks and Restrictions\n\nBIO Sites and their contents are protected pursuant to U.S. and international copyright laws.  All materials published on BIO Sites are the copyrighted property of BIO or any affiliated company, third party licensors, or the party credited.  BIO claims no copyright in any government or other public domain content that may be on our sites.  All trademarks, service marks and trade names, including but not limited to the BIO mark, as well as other marks, owned by BIO are protected by state, federal, and international trademark law.  All other trademarks appearing on BIO Sites are the property of their respective owners.\n\nExcept where otherwise noted, permission to use Materials (such as white papers, press releases, datasheets, and FAQs) from BIO Sites is granted, provided that (1) none of the copyright, trademark, or other proprietary notices are removed, (2) the Materials are not edited or modified in any way without prior written consent, (3) use of such Materials from the BIO Site is for informational and non-commercial or personal use only and may not be used in a misleading or deceptive manner, and (4) you do not use any Materials, without express written permission, in a manner that suggests an association with any of our groups, services, conferences, conventions, programs, initiatives or other activities.  Further, you agree to abide by all additional copyright notices, information, or restrictions contained in any material or content on the BIO Sites.\n\nMaterials specified above do not include any BIO trademarks, service marks or other protected intellectual property, including the design or layout of the BIO Sites or any other BIO owned, operated, licensed, or controlled site, which remain owned and protected by BIO.\n\nProprietary Rights in the Database, Database Content and Software\n\nUser shall not duplicate, distribute, sell, commercially exploit, create derivative works from, or otherwise make available the database or software or information or data contained therein, in any form or medium, to any third party. User acknowledges that the BIO One-on-One Partnering System and the operating software are proprietary to BIO or, in the case of the software licensed to BIO by its software provider (“Software Provider”), to such Software Provider, that the BIO One-on-One Partnering System and the operating software shall remain the exclusive property of BIO and its Software Provider, and that Customer has no rights therein other than as set forth herein.\n\nBIO has no objection to links made from other sites to BIO Sites, provided that you comply with the following requirements:\n\nYou may not frame or alter the appearance of BIO Sites.\n\nYou may not state or imply that BIO endorses, sponsors or otherwise approves your site or any other sites.\n\nYou may not use any BIO Trademarks or logos without prior written consent.\n\nIn view of the dynamic nature of the Internet, and the possibility of updates and changes, we request that your link enter BIO Sites at their home pages.\n\nYou must abide by all of the other BIO Terms and Conditions of use set forth herein.\n\nDue to the diverse nature of our web activities, websites within the BIO Internet family may have linking policies that differ from this policy.  In such cases, the linking policy of the particular BIO Site will be posted, and will supersede the Terms regarding linking to BIO Sites of this document.\n\nIf you download authorized software or applications from any BIO Site, the software or applications, including any files, images incorporated in or generated by the software or applications, and data and instructions accompanying the software or applications (collectively, the \"Software\") are licensed to you by BIO or our third party licensors for your personal, non-commercial use.  We do not transfer title to the Software to you.  We (or third-party licensors) retain full and complete title to the Software and all intellectual property rights therein.  Except as expressly authorized by us, you agree not to redistribute, sell, de-compile, reverse engineer, disassemble, or create derivative works based on the Software, in whole or in part.\n\nIf you have any questions regarding this notice, please send a E-mail to [web@bio.org].\n\nAt times BIO Sites may request ideas or materials that include but that are not limited to concepts, know-how, techniques, suggestions, and materials (collectively \"Submission(s)\").  Except as expressly provided in our Privacy Policy, in a separate written agreement between you and BIO, or otherwise expressly stated, by submitting any Submission, whether solicited by us or not, you are automatically granting BIO a royalty-free, perpetual, non-exclusive, unrestricted, worldwide license to use, reproduce, modify, adapt, publish, translate, publicly perform and display, create derivative works from and distribute such materials and/or ideas or incorporate such materials and/or ideas into any form, medium, or technology now known or later developed throughout the universe, and that all so-called \"moral rights\" to such Submissions have been waived.  This grant of rights means that such Submissions will be owned by BIO, and may be used without any payment to, or further authorization by you.  The foregoing grants shall include the right to exploit any proprietary rights in such communication, including but not limited to rights under copyright, trademark, service mark, or patent laws under any relevant jurisdiction.\n\nForums, E-mail, and Public Communications\n\nBIO Sites may include forums, chat rooms, e-mail function, or other areas (collectively \"Forums\"), where users can post or exchange information, ideas, opinions, photographs, images, videos, creative works or any other materials (collectively \"Messages\") with other users of the Site or the Internet.  In no event shall BIO assume or have any responsibility or liability for any Messages posted on Forums or for any claims, damages or losses resulting from their use or appearance on a BIO Site.  Children under the age of 18 are not authorized to post messages or participate in Forums on BIO Sites.\n\nBIO does not control Messages delivered to Forums, and BIO has no obligation to monitor such Forums.  If at any time BIO chooses, in its sole discretion, to monitor the Forums, BIO nonetheless assumes no responsibility for the content of the Messages, no obligation to modify or remove any inappropriate Messages, and no responsibility for the conduct of the user submitting any Messages.\n\nThe Messages do not necessarily reflect the views of BIO and are not necessarily reviewed prior to posting.  BIO makes no warranties, express or implied, as to the content of the Messages in the Forums or the accuracy or reliability of any Messages and other materials in the Forums.  BIO reserves the right at all times to disclose any information (including the identity of the persons providing information or materials on its Forums) as necessary to satisfy any law, regulation, or governmental request.  Further, BIO reserves the right to restrict, prohibit your use, and remove or edit Messages from any Forum at any time, for any reason.\n\nBy posting Messages (including but not limited to acts of uploading files, inputting data, or engaging in any other form of communication) through Forums, you are granting BIO a royalty-free, perpetual, non-exclusive, unrestricted, worldwide license to use, reproduce, modify, adapt, publish, translate, publicly perform and display, create derivative works from and distribute such materials and/or ideas or incorporate such materials and/or ideas into any form, medium, or technology now known or later developed throughout the universe, and that all so-called \"moral rights\" to such Messages have been waived.  This grant of rights means that such Messages will be owned by BIO, and may be used without any payment to, or further authorization by you.  The foregoing grants shall include the right to exploit any proprietary rights in such communication, including but not limited to rights under copyright, trademark, service mark, or patent laws under any relevant jurisdiction.\n\nIt is a condition of your use of Forums and BIO Sites that you do not:\n\nUse any Forums or BIO Sites for any illegal purposes (or to solicit any illegal act) including, but not limited to, violating applicable antitrust laws and regulations.\n\nRestrict or inhibit any other user from using and enjoying the Forums or BIO Sites;\n\nPost or transmit an unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, harassing, pornographic, profane, or indecent information of any kind, including images and language or unlawful material or any material that could constitute or encourage conduct that would be considered a criminal offense or give rise to civil liability, or otherwise violate any law;\n\nPost or transmit any message with bigoted, hateful, or racially offensive statements;\n\nPost any message that solicits gambling or engage in any gambling activity;\n\nTransmit or upload any information, software or other material that violates or infringes on the rights of others, including material that is an invasion of privacy or publicity rights or that is protected by copyright, trademark or other proprietary right, or derivative works with respect thereto, without first obtaining permission from the owner or rightful holder;\n\nPost or distribute any software or other materials that contain a virus or other harmful component;\n\nAdvertise or sell or solicit to others;\n\nUse the site or its services for the purposes of sending junk email, chain letters, duplicative or unsolicited messages or \"spamming,\" or in connection with contests, surveys, or pyramid schemes;\n\nTry to gain unauthorized access to an BIO Site, other users' accounts, or computers connected to the BIO Site though password mining or other means; or\n\nInterfere with another user's use and enjoyment of a BIO Site or any other individual's use and enjoyment of related services\n\nIf at any time you are not happy with the Forums or object to any material within Forums, your sole remedy is to cease using them.\n\nContests and Sweepstakes, Auctions, and Other Aactivities\n\nBIO Sites may contain certain activities including, without limitation, e-mail services, registration, contests, sweepstakes, and auctions (collectively \"Contests\").  Each Contest has its own rules, which you must read and agree to before you may enter.\n\nThird Party Content and Links to Other Sites\n\nAt certain places on BIO Sites, users may be able to link to other Internet addresses.  These other sites are not under the control of BIO, and you acknowledge that BIO is not responsible for the accuracy, copyright compliance, legality, decency, or any other aspect of such sites.  The inclusion of such a link does not imply endorsement of the site by BIO or any association with its operators.  Use of any information on BIO Sites or obtained from linked addresses is voluntary and reliance on it should only be undertaken after an independent review.  A link or reference herein to any specific commercial product, process or service by trademark name, trademark, service mark, manufacturer or otherwise does not constitute or imply endorsement, recommendation or favoring by BIO.\n\nUser access and use of BIO Sites, or portions thereof may be restricted through the use of a login and password registration mechanism or similar process (collectively \"User Account\").  You are responsible for maintaining the confidentiality of your User Account, and are fully responsible for all activities that occur under your User Account.  You agree to (a) immediately notify BIO of any unauthorized use of your User Account or any other breach of security, and (b) ensure that you exit from restricted areas at the end of each session.  We will not be liable for any loss or damage arising from your failure to comply with this provision.\n\nWe may change, suspend or discontinue any aspect of our online services at any time, including the availability of any feature, database, or content available at a BIO Site.  BIO also may impose limits on certain features and services or restrict your access to parts or all of a BIO Site(s) without notice or liability.\n\nWe respect the privacy of visitors to BIO Sites.  For more information about how we use and protect the personal information you may provide through our websites,please click here to review the website's privacy policy.    Note that BIO reserves the right to change its privacy policy at any time without notice.\n\nPlease note BIO Sites may contain links to other Internet websites.  Whenever you travel to another website you should review its privacy policy.  BIO is not responsible for the content or privacy practices of third-party sites.\n\nNotice and Procedure for Making Claims of Copyright Infringement\n\nWe may give notice to our users by means of a general notice on any BIO Site, electronic mail to a user's e-mail address in our records, or by written communication sent by first-class mail to a user's address in our records.\n\nBIO respects the rights of copyright holders and we ask our users to do the same.  If you believe that your work has been copied in a way that constitutes copyright infringement on a BIO Site, or your intellectual property rights have been otherwise violated, please provide BIO's Copyright Agent with the information required by the Online Copyright Infringement Liability Limitation Act of the Digital Millennium Copyright Act, 17 U.S.C. § 512.\n\nNotification must be submitted to the following Designated Agent:\n\nKen Johnson, EsqAssistant General Counsel & Compliance OfficerBiotechnology Innovation Organization1201 Maryland Avenue SWWashington, DC 20024Tele:       (202) 962-9200Fax:        (202) 488-6301E-Mail:  kjohnson@bio.org\n\nThis contact information is for notices of copyright infringement only.\n\nTo be effective, the notification must be a written communication that includes the following:\n\nA physical or electronic signature of person authorized to act on behalf of the owner of an exclusive right that is allegedly infringed;\n\nIdentification of the copyrighted work claimed to have been infringed, or if multiple copyrighted works at a single online site are covered by a single notification, a representative list of such works at that site;\n\nIdentification of the material that is claimed to be infringing or to be the subject of infringing activity and that is to be removed or access to which is to be disabled, and information reasonably sufficient to permit the service provider to locate the material;\n\nInformation reasonably sufficient to permit the service provider to contact the complaining party, such as an address, telephone number, and, if available, an electronic mail address at which the complaining party may be contacted;\n\nA statement that the complaining party has a good-faith belief that use of the material in the manner complained of is not authorized by the copyright owner, its agent, or the law; and\n\nA statement that the information in the notification is accurate and, under penalty of perjury, that the complaining party is authorized to act on behalf of the owner of an exclusive right that is allegedly infringed.\n\nThrough this provision BIO seeks to preserve any and all exemptions from liability that may be available under the copyright law, but does not necessarily stipulate that it is a service provider as defined in 17 U.S.C. § 512 or elsewhere in the law.\n\nNothing contained on BIO Sites is intended as, nor shall be construed as, legal advice, guidance, or interpretation.  No attorney-client relationship is established between BIO and you by your using BIO Sites.  The information provided on BIO Sites is for general informational purposes only, and questions about any law, statute, or regulation should be directed to an attorney with expertise in the relevant area.\n\nBIO SITES AND ALL MATERIALS, INFORMATION, SOFTWARE, PRODUCTS, AND SERVICES INCLUDED IN OR AVAILABLE THROUGH BIO SITES (THE \"CONTENT\") ARE PROVIDED \"AS IS\" AND \"AS AVAILABLE\" FOR YOUR USE.  BIO SITES INCLUDING CONTENT ARE PROVIDED WITHOUT WARRANTY OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NONINFRINGEMENT.  BIO, ITS MEMBERS, ANY AFFILIATED COMPANIES, ITS LICENSORS, AND ITS EMPLOYEES DO NOT WARRANT THAT BIO SITES AND CONTENT ARE ACCURATE, COMPLETE, RELIABLE, CORRECT, OR FREE FROM ERROR OR OMISSIONS; THAT BIO SITES WILL BE AVAILABLE AT ANY PARTICULAR TIME OR LOCATION; THAT ANY DEFECTS OR ERRORS WILL BE CORRECTED; OR THAT BIO SITES AND CONTENT ARE FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS.  FURTHERMORE, BIO, AND ON BEHALF OF ITS MEMBERS, ANY AFFILIATED COMPANIES, ITS LICENSORS, AND ITS EMPLOYEES HEREBY EXPRESSLY DISCLAIMS ANY AND ALL WARRANTIES OF TITLE AND/OR NON-INFRINGEMENT RELATED TO BIO SITES.  YOUR USE OF BIO SITES IS SOLELY AT YOUR OWN RISK.\n\nUNDER NO CIRCUMSTANCES SHALL BIO, ITS MEMBERS, ANY AFFILIATED COMPANIES, ITS LICENSORS, AND ITS EMPLOYEES BE LIABLE FOR ANY DIRECT, INDIRECT, PUNITIVE, INCIDENTAL, SPECIAL, OR CONSEQUENTIAL DAMAGES RELATED TO YOUR VIOLATION OF THESE TERMS OR THAT RESULT FROM THE USE OF, OR INABILITY TO USE, BIO SITES.  THIS LIMITATION APPLIES WHETHER THE ALLEGED LIABILITY IS BASED ON CONTRACT, TORT, NEGLIGENCE, STRICT LIABILITY, OR ANY OTHER BASIS, EVEN IF BIO HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.  BECAUSE SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL DAMAGES, BIO'S LIABILITY IN SUCH JURISDICTIONS SHALL BE LIMITED BUT ONLY TO THE EXTENT PERMITTED BY LAW.\n\nYou agree to indemnify and hold harmless and upon request defend, BIO, its members, any affiliated companies, its licensors, and its employees from all liabilities, claims, and expenses, including attorney's fees, that arise from your use or misuse of BIO Sites and/or breach of these Terms.  BIO reserves the right, at it own expense, to assume the exclusive defense and control of any matter otherwise subject to indemnification by you, in which event you will cooperate with the BIO in asserting any available defenses.\n\nBIO Sites are maintained by or on behalf of BIO, located in the District of Columbia, United States of America.  We make no representation that these materials are appropriate or available for use in any particular location.  If you use a BIO Site, you are responsible for compliance with applicable laws.  By downloading or using content or features of a BIO Site, you assume the responsibility for doing so in compliance with the law that applies in jurisdiction(s) where you are located.\n\nBIO makes no representation that materials on BIO Sites are appropriate or available for use in locations outside the United States, and accessing them from territories where their contents are illegal is prohibited.  Those who choose to access BIO Sites from other locations do so on their own initiative and are responsible for compliance with local laws.\n\nSoftware available through BIO Sites is subject to U.S. export controls. No software available from a BIO Site may be downloaded or otherwise exported or re-exported (i) into (or to a national or resident of) any country to which the U.S. now or in the future embargoes goods; or (ii) to anyone on the U.S. Treasury Department's list of Specially Designated Nationals, the U.S. Commerce Department's Table of Denial Orders, or anyone subject to any other U.S. export restrictions.  By downloading or using any software available on a BIO Site or from a link to a BIO Site, you agree to the foregoing and you warrant that you are not located in, under the control of, or a national or resident of any such country on any such list, or otherwise in violation of U.S. export restrictions.\n\nThis Agreement shall be governed by and construed in accordance with the laws of the District of Columbia, United States of America.  Actions brought under this Agreement shall be brought in the District of Columbia, provided that federal jurisdictional requirements are satisfied.  Users of a BIO Site agree and submit to the jurisdiction of such courts for the purpose of litigating any claim or action related to this Agreement.\n\nUnless otherwise specified herein or expressly stated on a relevant BIO Site, these terms constitute the entire agreement between you and BIO with respect to BIO Sites and supersedes all prior or contemporaneous communications and proposals (whether oral, written, or electronic) between you and BIO with respect to BIO Sites.  If any part of these Terms & Conditions or terms specific to a BIO Site is held invalid or unenforceable, then the remaining portions shall remain in full force and effect.\n\nThe section titles in the Terms are for convenience only and have no legal or contractual effect.\n\nBIO reserves the right, in its sole discretion, to terminate your access to all BIO Sites, a specific BIO Site, or an area of a BIO Site immediately and without notice.  If you have any problems with these Terms & Conditions or with a BIO Site, your sole and exclusive remedy is to cease using the website(s).\n\nIn the event that your access terminates as provided herein or you cease using a BIO Site(s), these Terms & Conditions shall survive.\n\nIf you have any questions regarding these Terms & Conditions, please contact us at [web@bio.org].  If you have any other questions regarding BIO Sites, please contact us at:\n\nWebsite CoordinatorBiotechnology Innovation Organization1201 Maryland Avenue SWWashington, DC 20024Tele:       (202) 962-9200Fax:        (202) 488-6301E-Mail:web@bio.org\n\nThese Terms & Conditions were last updated on February 24, 2009.",
    "author": "Unknown",
    "date": "Unknown",
    "category": null,
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/events?category=701",
    "title": "BIO Events",
    "text": "Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.\n\nSign up for the BIO.News Newsletter >\n\nJune 22-25, 2026 | San Diego, CA\n\nNovember 3-5, 2025Vienna, Austria\n\nJanuary 12-15, 2026San Francisco, CA\n\nExplore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.\n\nOur tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.\n\nAs the largest global non-profit biotechnology trade association representing startups to Fortune 500 companies, BIO is proud to host a portfolio of partnering conferences that not only unite and empower biotech innovators and their ecosystem to improve lives, but also offer a broad and unbiased venue to seek investment and BD&L opportunities. Review our comprehensive list of events below.\n\nJune 22-25, 2026 | San Diego, CA\n\nThrough education, collaboration and advocacy, BIO strives to drive a bio-revolution that cures patients, protects our climate, and nourishes humanity. Receive timely event updates, exclusive content, partnering and programming announcements, and more.\n\nReceive discounts at all BIO events, access the largest cost-savings program for the life sciences industry, and advocate for issues critical to your business. Join BIO today to take your company to the next level.",
    "author": "Unknown",
    "date": "Unknown",
    "category": null,
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/gooddaybio-archive",
    "title": "BIO.News Newsletter",
    "text": "Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.\n\nSign up for the BIO.News Newsletter >\n\nJune 22-25, 2026 | San Diego, CA\n\nNovember 3-5, 2025Vienna, Austria\n\nJanuary 12-15, 2026San Francisco, CA\n\nExplore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.\n\nOur tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.\n\nReceive the best resource for the biotech industry with BIO.News,the only daily newsletter at the intersection of biotech, politics and policy.",
    "author": "Unknown",
    "date": "Unknown",
    "category": null,
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/bio-videos",
    "title": "BIO Videos",
    "text": "Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.\n\nSign up for the BIO.News Newsletter >\n\nJune 22-25, 2026 | San Diego, CA\n\nNovember 3-5, 2025Vienna, Austria\n\nJanuary 12-15, 2026San Francisco, CA\n\nExplore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.\n\nOur tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.\n\nWatch some of the latest and greatest videos produced by BIO.",
    "author": "Unknown",
    "date": "Unknown",
    "category": null,
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://www.youtube.com/user/BIOchannel",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  },
  {
    "url": "https://www.bio.org/bio-priorities",
    "title": "BIO's Six Core Strategic Priorities",
    "text": "Join BIO as we champion for bringing new treatments to patients with serious medical conditions and to support policies that promote innovation and improve patient access.\n\nSign up for the BIO.News Newsletter >\n\nJune 22-25, 2026 | San Diego, CA\n\nNovember 3-5, 2025Vienna, Austria\n\nJanuary 12-15, 2026San Francisco, CA\n\nExplore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIO’s membership services.\n\nOur tools and initiatives on workforce development, diversity and inclusion are designed to advance a more globally competitive industry.\n\nBIO is committed to speaking up for the millions of families around the world who depend upon our success.\n\nExplore how we drive biotechnology innovation. Advancing newer and better medicines, therapeutics, and vaccines is a collective effort that involves an entire ecosystem, not just one person or company. This virtuous circle of innovation often begins with a patient or family expressing a need, and is followed by researchers at academic centers responding with innovative ideas. BIO's role is to protect, advance, and enlarge this innovation ecosystem.\n\nInnovation defines our mission and future direction, but innovation alone is not enough without universal access. No one should go without essential medicines. We must understand why this happens and address it. BIO is uniquely positioned to convene discussions, propose solutions, and help ensure universal access for all.\n\nWe must share the stories of lives transformed by medical miracles. It is crucial to highlight those in need, offering hope through their stories of perseverance and passion that define biotechnology's uniqueness. We must also spotlight extraordinary successes, challenges faced, and the important lessons learned from failures in the pursuit of life-changing innovation.\n\nEvery decision we make in the biotechnology industry should be guided by empathy. Imagine if you or a loved one faced a challenging disease—what choices would you hope for? Bringing this passion and purpose to our work not only makes for fulfilling careers, but also has a profound impact on the work we do and those we serve. In some thereapeutic areas, we may be changing small parts of the world, but for individuals and families affected by these conditions, our efforts mean the world.\n\nThe biotechnology industry is a critical national security asset. We must consider how to prepare for future pandemics and respond to potential bioterror attacks. Resilience and the ability to safeguard public health in extreme circumstances are paramount. Ensuring a vibrant public health system demonstrates the benefits of a free and democratic society. Collaboratively, entrepreneurs and companies can not only serve U.S. citizens and allies, but also benefit the entire globe.\n\nWe need to broaden our perspective on membership in BIO—not just in technical terms, but for individuals who recognize their stake in the success of biotechnology. It's crucial to connect at a personal level, showing why new medicines, vaccines for individuals, their children, and future generations. We are entering a new era of biotechnology, and we must demonstrate its immense value to all people.",
    "author": "Unknown",
    "date": "Unknown",
    "category": null,
    "has_sources": true,
    "source_links": [
      "https://bio.news",
      "https://bio.news/bio-events/",
      "https://bio.news/category/federal-policy/",
      "https://www.facebook.com/IAmBiotech",
      "https://twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization/",
      "https://www.youtube.com/user/BIOchannel",
      "https://informaconnect.com/bioeurope/",
      "http://www.rightmixmatters.org/",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://bio.news",
      "https://www.ctpop.org",
      "https://www.covidvaccinefacts.org",
      "https://www.facebook.com/IAmBiotech",
      "https://www.twitter.com/IAmBiotech",
      "https://www.linkedin.com/company/biotechnology-innovation-organization",
      "https://www.youtube.com/channel/UCuiIBYKDE4nKvhgJh-cPV4w"
    ],
    "is_opinion": false
  }
]